Thyroid Cancer Drugs Market Set for Remarkable Growth: Coverage of Sales of Cabozantinib-s-malate, Caprelsa and Cometriq



DUBLIN, Aug. 14, 2023 /PRNewswire/ — The “Thyroid Cancer Drugs Global Market Report 2023” has been added to ResearchAndMarkets.com’s offering. With an impressive compound annual growth rate (CAGR) of 14.0%, the global thyroid cancer drugs market is projected to expand from $0.71 billion…

Leave a Reply